| 2/19/2025 | IG | New Issue: AbbVie prices $4 billion of senior notes in four parts
|
| 2/18/2025 | IG | AbbVie comes to market with four-part offering of senior notes
|
| 2/18/2025 | BKIG | S&P gives AbbVie notes A-
|
| 2/18/2025 | BKIG | Moody's gives A3 to AbbVie notes
|
| 8/1/2024 | BKIG | Moody's moves AbbVie outlook to positive
|
| 2/23/2024 | IG | Market Commentary: Strong high-grade deal pace to close out February; funds, short-term inflows higher
|
| 2/23/2024 | IG | New Issue: AbbVie prices $15 billion of senior notes in seven tranches
|
| 2/21/2024 | BKIG | Moody’s rates AbbVie notes A3
|
| 2/21/2024 | BKIG | S&P assigns A- to AbbVie notes
|
| 2/21/2024 | IG | AbbVie to price six tranches of senior notes to fund Cerevel merger
|
| 2/9/2024 | IG | Market Commentary: Busy high-grade corporate deal pace continues; M&A-related supply increases; flows up
|
| 12/29/2023 | IG | Market Commentary: Outlook 2024: Mostly steady high-grade supply expected; less M&A forecast; coupons hit highs
|
| 12/6/2023 | BKIG | AbbVie will use cash and debt for $8.7 billion Cerevel acquisition
|
| 11/2/2023 | BKIG | S&P hikes AbbVie
|
| 8/29/2023 | BKIG | Moody’s upgrades AbbVie
|
| 11/17/2022 | BKIG | Moody's raises AbbVie
|
| 11/10/2022 | BKIG | S&P raises AbbVie outlook to positive
|
| 3/2/2022 | BKIG | Moody's alters AbbVie view to positive
|
| 5/13/2020 | IGLM | AbbVie gets tenders for $13.99 billion, €3.06 billion Allergan notes
|
| 5/8/2020 | BKIG | S&P cuts AbbVie
|
| 5/5/2020 | IGLM | AbbVie extends exchange for Allergan notes for expected last time
|
| 4/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
| 4/20/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
| 4/6/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
| 3/23/2020 | IGLM | Abbvie extends exchange offers for Allergan notes by two more weeks
|
| 2/24/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
| 1/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
| 12/31/2019 | IG | Outlook 2020: High-grade bond spreads mostly expected to improve; bank paper to grind tighter
|
| 12/31/2019 | IG | Market Commentary: Outlook 2020: High-grade bond supply to decline for third year; merger funding needs drop
|
| 12/24/2019 | IG | Market Commentary: High-grade primary market shuts down ahead of holidays; Charter tightens; AbbVie steady
|
| 12/20/2019 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
| 12/18/2019 | IG | Market Commentary: High-grade corporate bond supply winds down for year; FHLBank on tap; AbbVie firms
|
| 12/11/2019 | IG | Market Commentary: Sterling Bancorp offers fixed/floaters; Steel Dynamics firms; AbbVie, Bristol-Myers tight
|
| 12/10/2019 | IG | Market Commentary: CIBC prices $1.25 billion; Apollo, FS KKR in primary; Reinsurance Group on investor calls
|
| 11/27/2019 | IG | Market Commentary: High-grade primary action quiets ahead of holiday; light December volume eyed; Westpac stable
|
| 11/22/2019 | IG | Market Commentary: Light supply eyed for holiday week; Intel, Dominion Energy soft; AbbVie firms; Westpac stable
|
| 11/18/2019 | IG | Market Commentary: High-grade supply strong; Intel, Dominion Energy, LabCorp, Honda, Western Union, Ameren price
|
| 11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
| 11/18/2019 | IG | Market Commentary: Morning Commentary: Western Union, Intel, Dominion Gas, LabCorp, Ameren offer notes
|
| 11/15/2019 | IG | Market Commentary: Equifax upsizes; Western Union, S&P Global hold investor calls; AbbVie mixed; Edison firms
|
| 11/14/2019 | IG | Market Commentary: Corning, ANZ, Level 3, Nationwide, Kansas City, Edison, Genpact price; inflows lower
|
| 11/14/2019 | IG | Market Commentary: Morning Commentary: Strong high-grade supply continues; Corning, Edison, Genpact on tap
|
| 11/13/2019 | IG | Market Commentary: Hasbro, Enbridge, Equinor, Aon, L3Harris among high-grade issuers; credit spreads ease
|
| 11/13/2019 | IG | Market Commentary: Morning Commentary: High-grade supply climbs after AbbVie deal; Enbridge, Hasbro on tap
|
| 11/13/2019 | IG | New Issue: AbbVie prices $30 billion of senior notes in 10 tranches
|
| 11/12/2019 | IG | Market Commentary: Ford prices split-rated tap; Westpac offers dollar notes; heavy high-grade volume in pipeline
|
| 11/12/2019 | IG | Market Commentary: Morning Commentary: Heavy high-grade volume in pipeline for week; Westpac offers notes
|
| 11/8/2019 | IG | Market Commentary: JPMorgan prices $750 million tap; heavy volume expected in week ahead; Credit Suisse firms
|
| 11/8/2019 | IG | Market Commentary: Morning Commentary: High-grade primary quiets; AbbVie continues marketing; inflows up
|
| 11/7/2019 | IGLM | AbbVie announces early participation results of exchange offer for 18 series of Allergan notes
|
| 11/7/2019 | IG | Market Commentary: Patterson-UTI prices downsized notes; FHLBank prints; Hasbro considers deal; inflows reported
|
| 11/7/2019 | BKIG | Moody’s assigns Baa2 to AbbVie notes
|
| 11/7/2019 | IG | Market Commentary: Morning Commentary: Patterson-UTI markets notes; FHLBank prints; Hasbro considers deal
|
| 11/7/2019 | BKIG | S&P gives AbbVie’s notes A-, on negative watch
|
| 11/6/2019 | IG | Market Commentary: Cheniere, Vistra, Equinix, Healthpeak, Ryder, SEK price; AbbVie markets multiple-tranche deal
|
| 11/6/2019 | IG | AbbVie launches offering of senior notes to fund Allergan merger
|
| 10/25/2019 | BKIG | Moody’s assigns Baa2 to AbbVie's exchange notes
|
| 10/25/2019 | BKIG | S&P rates AbbVie notes A-
|
| 10/25/2019 | IGLM | AbbVie launches exchange offer for 18 series of Allergan notes
|
| 9/16/2019 | BKIG | Moody’s assigns Baa2 to AbbVie euro notes
|
| 9/16/2019 | BKIG | S&P rates AbbVie notes A-
|
| 6/26/2019 | IG | Market Commentary: High-grade registered primary market quiets; Telus prices; FS KKR Capital considers bond deal
|
| 6/26/2019 | IG | Hefty high-grade debt offering eyed for AbbVie, Allergan merger
|
| 6/25/2019 | BKIG | AbbVie gets $38 billion bridge loan to acquire Allergan, repay debt
|
| 6/25/2019 | BKIG | S&P puts Allergan on positive watch
|
| 6/25/2019 | BKIG | Moody’s affirms AbbVie
|
| 6/25/2019 | BKIG | S&P puts AbbVie on watch
|
| 9/14/2018 | IG | Market Commentary: U.S. Bancorp prices $500 million; steady supply forecast; AbbVie notes tighten; BNG firms
|
| 9/14/2018 | IG | Market Commentary: Morning Commentary: High-grade primary quiets after solid volume week; inflows increase
|
| 9/14/2018 | IG | New Issue: AbbVie gives details on $6 billion four-tranche issue of senior notes
|
| 9/13/2018 | IG | Market Commentary: AbbVie prices $6 billion; Prudential, BNG sell notes; high-grade funds post inflows
|
| 9/13/2018 | IG | New Issue: AbbVie prices $6 billion four-part offering of senior notes
|
| 9/13/2018 | BKIG | S&P gives A- to AbbVie notes
|
| 9/13/2018 | BKIG | Moody’s gives AbbVie notes Baa2
|
| 9/13/2018 | IG | Market Commentary: Morning Commentary: Prudential on tap; AbbVie offering eyed; Unibail-Rodamco prices
|
| 9/13/2018 | IG | AbbVie plans four-part offering of senior notes via four bookrunners
|
| 11/14/2016 | BKIG | S&P gives A- to AbbVie notes
|
| 11/14/2016 | BKIG | Moody’s: AbbVie notes Baa2
|
| 11/2/2016 | IGLM | AbbVie to repay 1.75% senior notes due 2017 using new issue proceeds
|
| 6/2/2016 | BKIG | Moody’s lowers AbbVie debt to Baa2
|
| 5/11/2016 | IG | Market Commentary: Starbucks, ConEd, Kansas City Southern bring new deals; AbbVie firms; credit spreads soften
|
| 5/11/2016 | IG | Market Commentary: Morning Commentary: High-grade primary market heats up; AbbVie notes tighten in secondary market
|
| 5/10/2016 | IG | New Issue: AbbVie details $7.8 billion five-part sale of senior notes
|
| 5/9/2016 | IG | Market Commentary: AbbVie, Chevron, Burlington Northern, Grainger price; bonds mixed; credit spreads mostly flat
|
| 5/9/2016 | IG | New Issue: AbbVie prices $7.8 billion of senior notes in five tranches
|
| 5/9/2016 | BKIG | Moody’s applies Baa2 to AbbVie notes
|
| 5/9/2016 | BKIG | S&P gives A- to AbbVie notes
|
| 5/9/2016 | IG | AbbVie plans to price five series of senior notes
|
| 4/28/2016 | BKIG | S&P lowers AbbVie
|
| 4/28/2016 | BKIG | Moody’s could drop AbbVie
|
| 12/31/2015 | IG | Market Commentary: Outlook 2016: Another record year for high-grade issuance; supply to be front-loaded in 2016
|
| 10/6/2015 | BKIG | S&P rates AbbVie loans A-1, A
|
| 6/24/2015 | IG | Market Commentary: Morning Commentary: Investment-grade credit spreads leak wider; AbbVie, Reynolds notes firm
|
| 5/19/2015 | IG | Market Commentary: Morning Commentary: High-grade bonds mixed ahead of supply; Credit Suisse firms; AbbVie soft
|
| 5/13/2015 | IG | Market Commentary: Morning Commentary: Lloyds Bank notes tighten; AbbVie bonds recover earlier losses
|
| 5/12/2015 | IG | Market Commentary: Morning Commentary: Verizon/AOL deal grabs market focus; AbbVie mixed; Shell notes flat
|
| 5/11/2015 | IG | Market Commentary: Morning Commentary: AbbVie bonds steady in secondary trade; Goldman Sachs paper improves
|
| 5/8/2015 | IG | Market Commentary: Primary’s pace to continue next week; credit spreads firm; Exxon Mobil bonds soft
|
| 5/7/2015 | IG | Market Commentary: Week’s supply tops $50 billion; Boston Scientific, Chevron Phillips price; AbbVie tight
|
| 5/7/2015 | IG | Market Commentary: Morning Commentary: AbbVie notes tighten in secondary market; AT&T bonds trade softer
|
| 5/6/2015 | IG | Market Commentary: Apple, Shell bring large deals to primary; existing Apple, Shell notes tighten
|
| 5/5/2015 | IG | Market Commentary: AbbieVie brings $16.7 billion deal; AT&T, Microsoft improve; Exxon, Canadian Pacific Rail soft
|
| 5/5/2015 | IG | New Issue: AbbVie prices $16.7 billion of notes in six parts for Pharmacyclics acquisition
|
| 5/5/2015 | BKIG | Moody's rates AbbVie notes Baa1
|
| 5/5/2015 | IG | S&P applies A to AbbVie notes
|
| 5/5/2015 | IG | AbbVie talks six-part offering of senior notes for Tuesday pricing
|
| 3/23/2015 | BKIG | AbbVie plans note offering to help replace $18 billion bridge loan
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | BKIG | AbbVie to use committed financing for Pharmacyclics acquisition, plans to repurchase shares post-closing
|
| 3/5/2015 | BKIG | S&P affirms AbbVie on acquisition news
|
| 3/5/2015 | IG | Moody’s reviews AbbVie
|
| 7/18/2014 | BKIG | AbbVie secures £13.5 billion bridge facility to fund merger with Shire
|
| 7/18/2014 | IG | Moody’s changes AbbVie to stable
|
| 7/18/2014 | IG | S&P might lower AbbVie
|
| 7/8/2014 | IG | Moody's leaves AbbVie unchanged
|
| 6/25/2014 | IG | S&P lowers AbbVie to stable
|
| 12/31/2013 | IG | Outlook 2014: High-grade primary issuance to decrease slightly in 2014 following record year
|
| 4/30/2013 | IG | Market Commentary: Apple brings record $17 billion deal, joins Boeing, RBC in primary; Apple notes trade tighter
|
| 11/9/2012 | IG | Market Commentary: Midday Commentary: Markets muted ahead of holiday weekend; AbbVie notes due 2022 active
|
| 11/9/2012 | IG | Market Commentary: No new deals to cap big week of issuance ahead of long weekend; Dow Chemical weakens
|
| 11/6/2012 | IG | Market Commentary: Dow Chemical, OneBeacon, Jones Lang bring deals ahead of election results; Interpublic firms
|
| 11/5/2012 | IG | Market Commentary: Midday Commentary: Issuers jump into high-grade market prior to election
|
| 11/5/2012 | IG | New Issue: Abbott Labs spinoff AbbVie prices upsized $14.7 billion of notes in six tranches
|
| 11/5/2012 | IG | Moody's rates AbbVie notes Baa1
|
| 11/5/2012 | IG | S&P rates AbbVie notes A
|
| 11/5/2012 | IG | Market Commentary: AbbVie prices huge deal after delay; Boardwalk Pipelines, Invesco sell; secondary sees volume
|
| 11/5/2012 | IG | Abbott Labs spinoff AbbVie pricing benchmark offering of notes in five parts on Monday
|
